Oxford Biomedica PLC Change of Registered Address (0119F)
February 16 2015 - 6:41AM
UK Regulatory
TIDMOXB
RNS Number : 0119F
Oxford Biomedica PLC
16 February 2015
Oxford BioMedica: Change of Registered Address
Oxford, UK - 16 February 2015: Oxford BioMedica plc (LSE: OXB),
("OXB" or "the Company") a leading gene and cell therapy company,
announces that the registered office address of the Company has
changed to:
Oxford BioMedica Plc
Windrush Court
Transport Way
Oxford
OX4 6LT
The registered address at Companies House has been changed with
immediate effect.
-Ends-
For further information, please contact:
Oxford BioMedica plc: Tel: +44 (0)1865
John Dawson, Chief Executive Officer 783 000
Tim Watts, Chief Financial Officer
Media Enquiries: Tel: +44 (0)20
Mary-Jane Elliott/ Matthew Neal/ Chris Welsh/ 3709 5700
Laura Thornton
Consilium Strategic Communications
Notes to editors
About Oxford BioMedica(R)
Oxford BioMedica plc (LSE: OXB) is a leading gene and cell
therapy company with an unrivalled portfolio of gene therapy
products in development and a platform of exclusive and pioneering
technologies with which it designs, develops and manufactures
unique gene-based medicines for some of world's largest
pharmaceutical companies. Leveraging its proprietary LentiVector(R)
IP and gene delivery system technology platform and unique tumour
antigen (5T4), Oxford BioMedica is advancing its pipeline of seven
gene therapy products addressing diseases for which there are
currently no treatments or that are inadequately treated today,
including ocular and central nervous system disorders. OXB
Solutions, the Company's industry-leading manufacturing and
development business, provides services to collaborators and
partners working in gene and cell therapy, including Novartis and
Immune Design Corp. In addition, the Company has licenced products
and IP to Sanofi, Pfizer, MolMed, Sigma-Aldrich, Biogen Idec,
Emergent BioSolutions and ImaginAb. Further information is
available at www.oxfordbiomedica.co.uk and www.oxbsolutions.co.uk
.
This information is provided by RNS
The company news service from the London Stock Exchange
END
CROGGUBWPUPAGGQ
Oxford Biomedica (LSE:OXB)
Historical Stock Chart
From Mar 2024 to Apr 2024
Oxford Biomedica (LSE:OXB)
Historical Stock Chart
From Apr 2023 to Apr 2024